Atlas Trials

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Clinical trial NCT06982547 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06982547
Sponsor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Rheumatoid Arthritis (RA)
Start date
2025-06-01
Primary completion
2027-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.